SLC26A3 and inflammatory bowel disease: The dysregulation of DRA’s functional expression is also known to contribute to gut microbiome dysbiosis and disrupt mucosal immune homeostasis through epithelial-immune cell crosstalk, ultimately leading to IBD-related diarrheal diseases [13,16,52,53,54,55].